Treatment patterns among US women diagnosed with endometriosis: a retrospective claims analyses pre- and post-diagnosis
A.M. Soliman,M. Fuldeore,H. Yang,E.X. Du,E.Q. Wu,C. Winkel
DOI: https://doi.org/10.1016/j.fertnstert.2014.07.987
IF: 6.7
2014-01-01
Fertility and Sterility
Abstract:ObjectiveSince endometriosis may remain undiagnosed for many years and treatments before diagnosis are rarely studied, we evaluated treatment patterns in women with endometriosis versus matched controls for 5 years before and after diagnosis.DesignCase-control retrospective claim analysis using the Truven Health MarketScan Databases.Materials and MethodsPatients aged 18-45 years with ≥1 endometriosis diagnosis (International Classification of Diseases code 617.xx) were matched 1:1 to women without endometriosis (controls) by age, region, and insurance type. The first endometriosis diagnosis date was assigned as the index date for the endometriosis patient and for the matching control. Continuous eligibility in a health plan for ≥1 year pre- and post-index was required. Use of endometriosis-related treatments was compared between patients and controls using McNemar’s tests for each of the pre- and post-index years.ResultsAmong 37,570 matched pairs selected, the mean age at index date was 36.4 years. Endometriosis patients had significantly higher medical and surgical usage than controls in the first year pre- and post-index. Pre-index usage of medications was: NSAIDs, 31.8% vs. 16.9%; GnRH agonists, 2.9% vs. 0.2%; analgesics, 47.5% vs. 25.4%; progestins, 14.0% vs. 5.6% while post-index usage was: NSAIDs, 41.7% vs. 17.3%; GnRH agonists, 8.9% vs. 0.2%; analgesics, 74.8% vs. 26.4%; progestins, 15.8% vs. 5.7%. For surgical procedures, pre-index usage was: laparoscopy, 4.7% vs. 0.8%, and hysterectomy, 1.1% vs. 0.5%, respectively, while post-index usage was: laparoscopy, 35.9% vs. 0.7%, and hysterectomy, 36.8% vs. 0.7%, respectively; all p<0.05. In each of the other 4 pre- and post-index years, yearly usage rate differences in treatments were much smaller but remained significantly higher for endometriosis patients for NSAIDs, analgesics, and laparoscopy.ConclusionThe study results show that endometriosis patients have significantly higher utilization of endometriosis-related pharmacological and surgical treatments than controls even before the endometriosis diagnosis, which suggests that endometriosis management and economic burden may begin well before diagnosis. The results also show a sharp rise in endometriosis treatments utilization immediately post diagnosis. ObjectiveSince endometriosis may remain undiagnosed for many years and treatments before diagnosis are rarely studied, we evaluated treatment patterns in women with endometriosis versus matched controls for 5 years before and after diagnosis. Since endometriosis may remain undiagnosed for many years and treatments before diagnosis are rarely studied, we evaluated treatment patterns in women with endometriosis versus matched controls for 5 years before and after diagnosis. DesignCase-control retrospective claim analysis using the Truven Health MarketScan Databases. Case-control retrospective claim analysis using the Truven Health MarketScan Databases. Materials and MethodsPatients aged 18-45 years with ≥1 endometriosis diagnosis (International Classification of Diseases code 617.xx) were matched 1:1 to women without endometriosis (controls) by age, region, and insurance type. The first endometriosis diagnosis date was assigned as the index date for the endometriosis patient and for the matching control. Continuous eligibility in a health plan for ≥1 year pre- and post-index was required. Use of endometriosis-related treatments was compared between patients and controls using McNemar’s tests for each of the pre- and post-index years. Patients aged 18-45 years with ≥1 endometriosis diagnosis (International Classification of Diseases code 617.xx) were matched 1:1 to women without endometriosis (controls) by age, region, and insurance type. The first endometriosis diagnosis date was assigned as the index date for the endometriosis patient and for the matching control. Continuous eligibility in a health plan for ≥1 year pre- and post-index was required. Use of endometriosis-related treatments was compared between patients and controls using McNemar’s tests for each of the pre- and post-index years. ResultsAmong 37,570 matched pairs selected, the mean age at index date was 36.4 years. Endometriosis patients had significantly higher medical and surgical usage than controls in the first year pre- and post-index. Pre-index usage of medications was: NSAIDs, 31.8% vs. 16.9%; GnRH agonists, 2.9% vs. 0.2%; analgesics, 47.5% vs. 25.4%; progestins, 14.0% vs. 5.6% while post-index usage was: NSAIDs, 41.7% vs. 17.3%; GnRH agonists, 8.9% vs. 0.2%; analgesics, 74.8% vs. 26.4%; progestins, 15.8% vs. 5.7%. For surgical procedures, pre-index usage was: laparoscopy, 4.7% vs. 0.8%, and hysterectomy, 1.1% vs. 0.5%, respectively, while post-index usage was: laparoscopy, 35.9% vs. 0.7%, and hysterectomy, 36.8% vs. 0.7%, respectively; all p<0.05. In each of the other 4 pre- and post-index years, yearly usage rate differences in treatments were much smaller but remained significantly higher for endometriosis patients for NSAIDs, analgesics, and laparoscopy. Among 37,570 matched pairs selected, the mean age at index date was 36.4 years. Endometriosis patients had significantly higher medical and surgical usage than controls in the first year pre- and post-index. Pre-index usage of medications was: NSAIDs, 31.8% vs. 16.9%; GnRH agonists, 2.9% vs. 0.2%; analgesics, 47.5% vs. 25.4%; progestins, 14.0% vs. 5.6% while post-index usage was: NSAIDs, 41.7% vs. 17.3%; GnRH agonists, 8.9% vs. 0.2%; analgesics, 74.8% vs. 26.4%; progestins, 15.8% vs. 5.7%. For surgical procedures, pre-index usage was: laparoscopy, 4.7% vs. 0.8%, and hysterectomy, 1.1% vs. 0.5%, respectively, while post-index usage was: laparoscopy, 35.9% vs. 0.7%, and hysterectomy, 36.8% vs. 0.7%, respectively; all p<0.05. In each of the other 4 pre- and post-index years, yearly usage rate differences in treatments were much smaller but remained significantly higher for endometriosis patients for NSAIDs, analgesics, and laparoscopy. ConclusionThe study results show that endometriosis patients have significantly higher utilization of endometriosis-related pharmacological and surgical treatments than controls even before the endometriosis diagnosis, which suggests that endometriosis management and economic burden may begin well before diagnosis. The results also show a sharp rise in endometriosis treatments utilization immediately post diagnosis. The study results show that endometriosis patients have significantly higher utilization of endometriosis-related pharmacological and surgical treatments than controls even before the endometriosis diagnosis, which suggests that endometriosis management and economic burden may begin well before diagnosis. The results also show a sharp rise in endometriosis treatments utilization immediately post diagnosis.